DIVI ETF Holdings

Holdings

Symbol	Grade	Price % Change	Allocation
NVO	D	0.47	2.49
TM	C	0.99	1.69
NVS	B	0.28	1.51

Represented by ETF Holdings

Keywords: Active Pharmaceutical Ingredients Animal Health Anti Diabetic Drugs Antibiotics Auto Parts Automotive Industry Biopharmaceutical Biotechnology Blood Test Cars Contact Lens Contact Lenses Diabetes Diabetes Care Diagnostic Products Disposable Product Disposable Products Drugs E Commerce Marketplace Endocrine System

Industries: Auto Manufacturers Biotechnology Drug Manufacturers - Major

Recent News for Franklin International Core Dividend Tilt Index ETF & its Holdings

Date	Stock	Title
May 6	NVO	Investors Pile Into Amgen in Search of Next Obesity Drug Payout
May 6	NVO	Novo Nordisk doses first subject in Phase I trial of NLRP3 inhibitor
May 6	TM	TIMELINE-UAW workers ratify deal with Daimler as focus shifts to voting at Mercedes
May 6	NVO	'Ozempic Ftw:' Elon Musk Touts Novo Nordisk's Blockbuster Drug As Solution To Childhood Obesity Problem
May 5	NVS	Questor: this medical stock is expensive – but worth paying for
May 5	NVS	2 Magnificent Dividend Stocks to Hold for the Next Decade
May 4	TM	5 Japanese Cars To Stay Away From Buying
May 4	NVO	Move Over, Mounjaro. Eli Lilly Has Another Blockbuster in the Making
May 4	NVO	Can Pfizer Challenge Lilly and Novo Nordisk in the Obesity Market?
May 3	TM	A Week Of Fast-Moving Stocks Ahead: Disney, Toyota, Ferrari, Constellation
May 3	TM	Disney earnings, Fedspeak: What to Watch Next Week
May 3	NVO	Amgen's peek at its GLP-1 drug trial results heightens competition in obesity market
May 3	NVO	Novo Nordisk A/S (NYSE:NVO) Q1 2024 Earnings Call Transcript
May 3	NVO	Analyst unveils Amgen stock price target after weight-loss drug data
May 3	NVO	The FTC Cracks Down On Novo Nordisk's Ozempic
May 3	TM	Toyota Stock Is Trouncing Tesla. Hybrids Aren’t the Only Reason.
May 3	NVS	Alnylam (ALNY) Q1 Loss Narrower Than Expected, Sales Rise Y/Y
May 3	NVO	Weight-loss drug competition heats up. Is Wegovy in trouble?
May 3	NVO	Pharma Stock Roundup: LLY, NVO, PFE Q1 Results, JNJ's New Plan to Resolve Talc Claims
May 3	TM	Stocks to watch next week: BP, Saudi Aramco, Uber, and interest rates

Franklin International Core Dividend Tilt Index ETF is an exchange traded fund launched by Franklin Resources, Inc. The fund is managed by Franklin Advisory Services, LLC. It invests in public equity markets of global ex-US/Canada region. The fund invests in stocks of companies operating across diversified sectors. The fund invests in value, momentum and less volatile stocks of companies across diversified market capitalization. It invests in dividend paying stocks of companies. The fund seeks to track the performance of the Morningstar Developed Markets ex-North America Dividend Enhanced Select Index, by using full replication technique. Franklin International Core Dividend Tilt Index ETF was formed on June 1, 2016 and is domiciled in the United States.
Exchange Traded Funds SPDR Dividend S&P 500 Dividend Aristocrats

ETF Components for DIVI - Franklin International Core Dividend Tilt Index ETF